NEW YORK, Jan. 5, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE Content Advisory: Pre-Market Update + NYSE Becomes Exclusive Stock Exchange Partner of America250 jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2854410/NYSE_Market_Update_Jan_5.mp4’, image: ‘https://mma.prnasia.com/media2/2854410/NYSE_Market_Update_Jan_5.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on January 5th

Stocks open fractionally higher as Wall Street kicks off its first full week of 2026 trading; technology shares continue to outperform in extended trade. NYSE-listed oil giants surge after the U.S. ousted Venezuela’s President Nicolás Maduro: Exxon Mobil up 4.3% and Chevron up 7.8% NYSE partners with America 250 to celebrate the nation’s semi-quincentennial; today’s Opening Bell will be rung by the New York State Department of Military and Naval Affairs.

Opening BellThe New York National Guard is recognizing the service of the men and women of the New York Army and Air National Guard

Closing BellThrivent celebrates its growing suite of ETF products surpassing $1 billion in assets under management

Click here to download the NYSE TV App

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

CARAVELLE INTERNATIONAL GROUP ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE DEFICIENCY

SINGAPORE, Aug. 6, 2024 /PRNewswire/ — On July 26, 2024, Caravelle International Group…

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

SHANGHAI, Aug. 4, 2026 /PRNewswire/ — AsymBio, a biologics-focused Contract Development and…

Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis

HONG KONG, Jan. 19, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) announced that its supplemental…